JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:588-593, doi:10.1016/j.jacc.2004.04.038
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gisolf, J.
Right arrow Articles by Karemaker, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gisolf, J.
Right arrow Articles by Karemaker, J. M.

CLINICAL RESEARCH

Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response

Janneke Gisolf, MSc*,*, Berend E. Westerhof, MSc{dagger}, Nynke van Dijk, MD{ddagger}, Karel H. Wesseling, MSc§, Wouter Wieling, MD, PhD{ddagger} and John M. Karemaker, PhD*

* Department of Physiology, Academic Medical Center, Cardiovascular Research Institute, AmsterdamNetherlands
{dagger} TNO-TPD-BMI, Academic Medical Center, Cardiovascular Research Institute, AmsterdamNetherlands
{ddagger} Department of Internal Medicine, Academic Medical Center, Cardiovascular Research Institute, Amsterdam, Netherlands
§ Finapres Medical Systems, Amsterdam, the Netherlands

Manuscript received March 15, 2004; revised manuscript received March 26, 2004, accepted April 6, 2004.

* Reprint requests and correspondence: Ms. Janneke Gisolf, Department of Physiology, Room M01-07, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, the Netherlands.
j.gisolf{at}amc.uva.nl

OBJECTIVES: We set out to determine the effect of sublingual nitroglycerin (NTG), as used during routine tilt testing in patients with unexplained syncope, on hemodynamic characteristics and baroreflex control of heart rate (HR) and systemic vascular resistance (SVR).

BACKGROUND: Nitroglycerin is used in tilt testing to elicit a vasovagal response. It is known to induce venous dilation and enhance pooling. Also, NTG is lipophilic and readily passes cell membranes, and animal studies suggest a sympatho-inhibitory effect of NTG on circulatory control.

METHODS: Routine tilt testing was conducted in 39 patients with suspected vasovagal syncope (age 36 ± 16 years, 18 females). Patients were otherwise healthy and free of medication. Before a loss of consciousness set in, oncoming syncope was cut short by tilt-back or counter-maneuvers. Finger arterial pressure was monitored continuously (Finapres). Left ventricular stroke volume (SV) was computed from the pressure pulsations (Modelflow). Spontaneous baroreflex control of HR was estimated in the time and frequency domains.

RESULTS: During tilt testing, 22 patients developed presyncope. After NTG administration but before presyncope, SV and cardiac output (CO) decreased (p < 0.001), whereas SVR and HR increased (p < 0.001) in all patients. Arterial pressure was initially maintained. Baroreflex sensitivity decreased after NTG. On Cox regression analysis, the occurrence of a vasovagal response was related to a drop in SV after NTG (hazard ratio 0.86, p = 0.005).

CONCLUSIONS: The cardiovascular response to NTG is similar in vasovagal and non-vasovagal patients, but more pronounced in those with tilt-positive results. The NTG-facilitated presyncope appears to be CO-mediated, and there is no evidence of NTG-induced sympathetic inhibition.

Abbreviations and Acronyms
  BRS = baroreflex sensitivity
  CO = cardiac output
  DAP = diastolic arterial pressure
  HR = heart rate
  IBI = interbeat interval
  MAP = mean arterial pressure
  NO = nitric oxide
  NTG = nitroglycerin
  SAP = systolic arterial pressure
  SNP = sodium nitroprusside
  SV = stroke volume
  SVR = systemic vascular resistance
  VVS = vasovagal syncope




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. E. Westerhof, J. Gisolf, J. M. Karemaker, K. H. Wesseling, N. H. Secher, and J. J. van Lieshout
Time course analysis of baroreflex sensitivity during postural stress
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2864 - H2874.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Fuca, M. Dinelli, P. Suzzani, S. Scarfo, F. Tassinari, and P. Alboni
The venous system is the main determinant of hypotension in patients with vasovagal syncope
Europace, October 1, 2006; 8(10): 839 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. T. P. Krediet, I. G. J. M. de Bruin, K. S. Ganzeboom, M. Linzer, J. J. van Lieshout, and W. Wieling
Leg crossing, muscle tensing, squatting, and the crash position are effective against vasovagal reactions solely through increases in cardiac output
J Appl Physiol, November 1, 2005; 99(5): 1697 - 1703.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.